NYSE - Nasdaq Real Time Price USD

Medtronic plc (MDT)

79.74

+0.49

(+0.62%)

At close: 4:00 PM EDT

79.21

-0.53

(-0.66%)

After hours: 5:33 PM EDT

Medtronic receives FDA approval for Inceptiv™ closed-loop spinal cord stimulator

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that the U.S. Food and Drug Administration (FDA) has approved the Inceptiv™ closed-loop rechargeable spinal cord stimulator (SCS) for the treatment of chronic pain. Inceptiv is the first Medtronic SCS device to offer a closed-loop feature that senses biological signals along the spinal cord and automatically adjusts stimulation in real time, keeping therapy in harmony with the motions of daily life.

CNW Group 9 hours ago

MDT
+0.62%
20 Fastest Growing Health Tech Companies in the World

In this article, we will be taking a look at the 20 fastest growing health tech companies in the world. If you do not want to learn about the trends in digital health market, head straight to the 5 Fastest Growing Health tech Companies in the World. Explosive Growth and Key Trends in the Digital […]

Insider Monkey yesterday

TDOC

SNY

GSK
Calculating The Intrinsic Value Of Medtronic plc (NYSE:MDT)

Key Insights The projected fair value for Medtronic is US$100 based on 2 Stage Free Cash Flow to Equity With US$80.38...

Simply Wall St. yesterday

MDT
+0.62%
Medtronic PLC (MDT) Is a Trending Stock: Facts to Know Before Betting on It

Zacks.com users have recently been watching Medtronic (MDT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks 2 days ago

MDT
+0.62%
Medtronic names Yarmela Pavlovic as chief regulatory officer

Pavlovic, who was a partner at the law firm Manatt, Phelps & Phillips before joining Medtronic, will gain a new title, but her role will stay the same.

MedTech Dive 2 days ago

MDT
+0.62%
Boston Scientific, Dexcom and Edwards next as earnings season rolls on

J.P. Morgan analysts expect this week’s results to be “very good” following reports from J&J, Abbott and Intuitive Surgical.

MedTech Dive 3 days ago

BSX
-0.12%
EW

MDT
+0.62%
Medtronic (MDT) Laps the Stock Market: Here's Why

Medtronic (MDT) reachead $80.57 at the closing of the latest trading day, reflecting a +1.37% change compared to its last close.

Zacks 4 days ago

MDT
+0.62%
Is Medtronic plc's (NYSE:MDT) Stock On A Downtrend As A Result Of Its Poor Financials?

Medtronic (NYSE:MDT) has had a rough three months with its share price down 8.1%. Given that stock prices are usually...

Simply Wall St. 5 days ago

MDT
+0.62%
Medtronic: Americans Favor Quality Over Quantity in Pursuit of Longevity

According to a new survey from Medtronic and Morning Consult, nearly two-thirds of U.S. adults say they'd opt for a shorter, healthier life than a longer one with health issues DUBLIN, IRELAND / ACCESSWIRE / April 19, 2024 / Americans overwhelmingly ...

ACCESSWIRE 7 days ago

MDT
+0.62%
Here's Why You Should Retain Medtronic (MDT) Stock for Now

Investors continue to be optimistic about Medtronic (MDT) due to the strength of its Neurosurgery and Cardiovascular portfolios.

Zacks 8 days ago

MDT
+0.62%
CAH

DVA
Medtronic Stock: Buy, Sell, or Hold?

Can this struggling healthcare specialist turn things around?

Motley Fool 8 days ago

MDT
+0.62%
^GSPC
Americans favor quality over quantity in pursuit of longevity

Americans overwhelmingly say that when they think about longevity, it's more than just living longer—it's about living their healthiest, best lives. While most want to live to 90—well past the average U.S. life expectancy of 77.5 years—nearly two-thirds (66%) would choose a shorter, healthier life over a longer one with health issues. These findings, from a survey conducted by global healthcare technology leader Medtronic with Morning Consult, highlight a gap between U.S. adults' desire to live

CNW Group 9 days ago

MDT
+0.62%
The Zacks Analyst Blog Highlights Mastercard, Netflix, Coca-Cola, Berkshire Hathaway and Medtronic

Mastercard, Netflix, Coca-Cola, Berkshire Hathaway and Medtronic are included in this Analyst Blog.

Zacks 9 days ago

NFLX

MA

KO
Medtronic (MDT) Stock Sinks As Market Gains: What You Should Know

Medtronic (MDT) concluded the recent trading session at $79.35, signifying a -1.1% move from its prior day's close.

Zacks 10 days ago

MDT
+0.62%
^GSPC
Cash Burn: 3 Dividend Aristocrats to Dump for Buyback Plays

Although dividend investing has plenty of research backing its efficacy, it’s a slow burn. Further, it may incur high opportunity costs during broad-market rallies, such as what we saw during the bull in the Nasdaq last year. If one seeks capital appreciation potential, plan to sell some Dividend Aristocrats. Rather, invest in companies pursuing aggressive buyback activities, which could lead to significant short-term capital gains. The Dividend Aristocrats to sell in this list are marked with i

InvestorPlace 10 days ago

ADM

MDT
+0.62%
SPGI
Q1 Earnings Scorecard and Analyst Reports for Mastercard, Netflix & Coca-Cola

Today's Research Daily features a real-time update on the Q1 earnings season and new research reports Mastercard (MA), Netflix (NFLX) and Coke (KO) and others.

Zacks 10 days ago

NFLX

KO

MA
2 Artificial Intelligence (AI) in Healthcare Stocks to Buy and Hold for Great Long-Term Potential

These companies have gotten in on AI early and could emerge as winners.

Motley Fool 10 days ago

MRNA

MDT
+0.62%
Edwards pushes back on Medtronic’s head-to-head TAVR trial

Edwards Lifesciences and Wall Street analysts questioned the results of Medtronic’s women-focused study, claiming the data are inconsistent with real-world evidence.

MedTech Dive 11 days ago

MDT
+0.62%
Medtronic PLC (MDT) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching Medtronic (MDT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks 14 days ago

MDT
+0.62%
Why Wall Street Got Even More Excited About The Glucose Monitor — And How Dexcom, Abbott Labs Stand To Benefit

Metabolic health is all the rage, helped by the advent of weight-loss drugs and continuous glucose monitors. Can they change disease forever?

Investor's Business Daily 14 days ago

ABT
+0.63%
DXCM

MDT
+0.62%

Performance Overview

Return	MDT	S&P 500
YTD	-2.40%	+6.92%
1-Year	-8.12%	+25.26%
3-Year	-33.62%	+22.00%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Medtronic plc (MDT)

Medtronic receives FDA approval for Inceptiv™ closed-loop spinal cord stimulator

20 Fastest Growing Health Tech Companies in the World

Calculating The Intrinsic Value Of Medtronic plc (NYSE:MDT)

Medtronic PLC (MDT) Is a Trending Stock: Facts to Know Before Betting on It

Medtronic names Yarmela Pavlovic as chief regulatory officer

Boston Scientific, Dexcom and Edwards next as earnings season rolls on

Medtronic (MDT) Laps the Stock Market: Here's Why

Is Medtronic plc's (NYSE:MDT) Stock On A Downtrend As A Result Of Its Poor Financials?

Medtronic: Americans Favor Quality Over Quantity in Pursuit of Longevity

Here's Why You Should Retain Medtronic (MDT) Stock for Now

Medtronic Stock: Buy, Sell, or Hold?

Americans favor quality over quantity in pursuit of longevity

The Zacks Analyst Blog Highlights Mastercard, Netflix, Coca-Cola, Berkshire Hathaway and Medtronic

Medtronic (MDT) Stock Sinks As Market Gains: What You Should Know

Cash Burn: 3 Dividend Aristocrats to Dump for Buyback Plays

Q1 Earnings Scorecard and Analyst Reports for Mastercard, Netflix & Coca-Cola

2 Artificial Intelligence (AI) in Healthcare Stocks to Buy and Hold for Great Long-Term Potential

Edwards pushes back on Medtronic’s head-to-head TAVR trial

Medtronic PLC (MDT) is Attracting Investor Attention: Here is What You Should Know

Why Wall Street Got Even More Excited About The Glucose Monitor — And How Dexcom, Abbott Labs Stand To Benefit

Performance Overview